MBOT Microbot Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MBOT

Price (delayed)

$1.26

Market cap

$14.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.2

Enterprise value

$13.62M

Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary ...

Highlights
Microbot Medical's debt has plunged by 51% YoY and by 23% from the previous quarter
Microbot Medical's EPS has increased by 39% YoY and by 19% QoQ
MBOT's quick ratio is up by 42% YoY but it is down by 27% from the previous quarter
The equity has increased by 33% YoY but it has decreased by 22% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.microbotmedical.com
Peers: NRC NWBO

Key stats

What are the main financial stats of MBOT
Market
Shares outstanding
11.71M
Market cap
$14.75M
Enterprise value
$13.62M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$10.58M
EBITDA
-$10.48M
Free cash flow
-$9.21M
Per share
EPS
-$1.2
Free cash flow per share
-$0.79
Book value per share
$0.63
Revenue per share
$0
TBVPS
$0.76
Balance sheet
Total assets
$8.89M
Total liabilities
$1.53M
Debt
$245,000
Equity
$7.36M
Working capital
$6.92M
Liquidity
Debt to equity
0.03
Current ratio
5.64
Quick ratio
5.5
Net debt/EBITDA
0.11
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-119.2%
Return on equity
-146.2%
Return on invested capital
-223.4%
Return on capital employed
-143.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MBOT stock price

How has the Microbot Medical stock price performed over time
Intraday
-3.82%
1 week
-4.55%
1 month
8.62%
1 year
-72.55%
YTD
-58.14%
QTD
-9.35%

Financial performance

How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.86M
Net income
-$10.58M
Gross margin
N/A
Net margin
N/A
MBOT's net income is up by 25% year-on-year and by 9% since the previous quarter
MBOT's operating income is up by 23% year-on-year and by 8% since the previous quarter

Growth

What is Microbot Medical's growth rate over time

Valuation

What is Microbot Medical stock price valuation
P/E
N/A
P/B
2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Microbot Medical's EPS has increased by 39% YoY and by 19% QoQ
The equity has increased by 33% YoY but it has decreased by 22% QoQ
The stock's price to book (P/B) is 31% less than its 5-year quarterly average of 2.9 and 29% less than its last 4 quarters average of 2.8

Efficiency

How efficient is Microbot Medical business performance
The company's return on invested capital has surged by 69% YoY and by 30% QoQ
The ROE has grown by 15% from the previous quarter but it has contracted by 4.4% YoY
MBOT's return on assets is up by 13% since the previous quarter but it is down by 2.8% year-on-year

Dividends

What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBOT.

Financial health

How did Microbot Medical financials performed over time
MBOT's quick ratio is up by 42% YoY but it is down by 27% from the previous quarter
The current ratio is up by 41% YoY but it is down by 28% from the previous quarter
Microbot Medical's debt is 97% less than its equity
Microbot Medical's debt to equity has shrunk by 67% YoY
Microbot Medical's debt has plunged by 51% YoY and by 23% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.